Drug:
Reaction: THERAPY INTERRUPTED
20250101 - 20251231
No. 1201 - 1300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1201 | 24979044 |
US |
57 | 2 |
Product prescribing issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1202 | 24979251 |
US |
||
Inability to afford medication, Therapy interrupted, Pain, |
||||
ABATACEPT, |
||||
| 1203 | 24979298 |
US |
70 | 2 |
Therapy interrupted, Product prescribing issue, Limb discomfort, |
||||
ABATACEPT, |
||||
| 1204 | 24979299 |
US |
60 | 1 |
Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1205 | 24979374 |
US |
2 | |
Hospitalisation, Blood iron decreased, Aspergillus infection, Pneumonia fungal, White blood cell count decreased, Deafness, Constipation, Weight increased, Gliosis, Peripheral swelling, Immune system disorder, Cardiac disorder, Ocular discomfort, Ill-defined disorder, Sputum increased, Head discomfort, Adverse drug reaction, Cough, Fatigue, Tinnitus, Unevaluable event, Hypoacusis, Therapy interrupted, |
||||
AMIKACIN, AMIKACIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 1206 | 24979418 |
73 | 1 | |
Cataract, Anxiety, Therapy interrupted, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, MIRTAZAPINE, |
||||
| 1207 | 24979755 |
US |
2 | |
Device difficult to use, Therapy interrupted, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, |
||||
| 1208 | 24980219 |
CA |
76 | 1 |
Haemorrhage, Therapy interrupted, Urinary retention postoperative, Haematuria, Urinary retention, |
||||
APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 1209 | 24980530 |
GB |
1 | |
Hospitalisation, Therapy interrupted, |
||||
CLOZAPINE, |
||||
| 1210 | 24980696 |
US |
||
Coronary artery bypass, Ankle operation, Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METOPROLOL TARTRATE, METOPROLOL, LISINOPRIL, HYDROCHLOROTHIAZIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, AMLODIPINE, |
||||
| 1211 | 24980703 |
US |
61 | 2 |
Psoriatic arthropathy, Cyst, Therapy interrupted, Insurance issue, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 1212 | 24981050 |
US |
80 | 1 |
Glaucoma, Rash pruritic, Unevaluable event, Dysarthria, Condition aggravated, Condition aggravated, Coordination abnormal, Condition aggravated, Incorrect route of product administration, Incorrect dose administered by device, Therapy interrupted, Device issue, Wrong technique in product usage process, Hyperhidrosis, Gait disturbance, Asthenia, Drug ineffective, Cough, Confusional state, Headache, Dyskinesia, |
||||
LEVODOPA, LEVODOPA, LEVODOPA, LEVODOPA, LEVODOPA, CARBIDOPA AND LEVODOPA, TELMISARTAN, FAMOTIDINE, |
||||
| 1213 | 24981063 |
US |
1 | |
Dry mouth, Muscular weakness, Intentional underdose, Device issue, Incorrect dose administered by device, Product residue present, Device difficult to use, Wrong technique in device usage process, Wrong schedule, Therapy interrupted, Device delivery system issue, Productive cough, |
||||
LEVODOPA, LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, RASAGILINE, RASAGILINE MESYLATE, |
||||
| 1214 | 24981077 |
US |
86 | 1 |
Limb discomfort, Feeling abnormal, Wrong technique in device usage process, Product communication issue, Limb discomfort, Device issue, Device difficult to use, Product cleaning inadequate, Device defective, Product dose omission issue, Device use issue, Therapy interrupted, Cough, |
||||
LEVODOPA, LEVODOPA, LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, ROTIGOTINE, |
||||
| 1215 | 24981226 |
PT |
1 | |
Thrombocytosis, Neutrophilia, Polycythaemia, Leukocytosis, Therapy interrupted, Product availability issue, |
||||
PEGINTERFERON ALFA-2A, |
||||
| 1216 | 24981398 |
US |
73 | 2 |
Insurance issue, Therapy interrupted, Product supply issue, Diarrhoea, Fatigue, Pain, Vitamin B complex deficiency, Product dose omission issue, |
||||
LENALIDOMIDE, |
||||
| 1217 | 24981486 |
82 | 1 | |
Viral infection, Therapy interrupted, |
||||
DEFERASIROX, ALLOPURINOL, APIXABAN, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ROSUVASTATIN, EMPAGLIFLOZIN, |
||||
| 1218 | 24981490 |
52 | 2 | |
Illness, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 1219 | 24981657 |
US |
2 | |
Rheumatoid arthritis, Migraine, Therapy interrupted, Insurance issue, |
||||
CERTOLIZUMAB PEGOL, PROPRANOLOL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, AZELAIC ACID, |
||||
| 1220 | 24981660 |
US |
47 | 2 |
Therapy interrupted, Plasma cell myeloma, Product dispensing error, |
||||
LENALIDOMIDE, |
||||
| 1221 | 24981830 |
2 | ||
Surgery, Pain, Therapy interrupted, |
||||
ETANERCEPT, CALCIUM, IRON, ZOLEDRONIC ACID, ERGOCALCIFEROL, |
||||
| 1222 | 24981842 |
1 | ||
Renal cancer, Cerebrovascular accident, Therapy interrupted, |
||||
ADALIMUMAB, PANTOPRAZOLE, TIRZEPATIDE, HYDROCHLOROTHIAZIDE, PREDNISONE, GLIPIZIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LISINOPRIL, |
||||
| 1223 | 24982035 |
US |
77 | 2 |
Insurance issue, Therapy interrupted, Off label use, |
||||
LENALIDOMIDE, |
||||
| 1224 | 24982087 |
US |
55 | 2 |
Rheumatoid arthritis, Therapy interrupted, Insurance issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 1225 | 24982714 |
US |
||
Hospitalisation, Therapy interrupted, |
||||
| 1226 | 24982763 |
US |
71 | 1 |
Pleural effusion, Pericardial effusion, Dyspnoea, Therapy interrupted, Insurance issue, |
||||
RIFAXIMIN, |
||||
| 1227 | 24982765 |
US |
46 | 1 |
Back disorder, Inability to afford medication, Therapy interrupted, |
||||
RIFAXIMIN, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LACTULOSE, NADOLOL, MORPHINE, FUROSEMIDE, |
||||
| 1228 | 24985103 |
41 | 2 | |
Influenza, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 1229 | 24985106 |
42 | 2 | |
Pneumonia, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 1230 | 24985176 |
54 | 2 | |
Illness, Therapy interrupted, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 1231 | 24985186 |
45 | 2 | |
Illness, Antibiotic therapy, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 1232 | 24985255 |
82 | 1 | |
Diarrhoea, Peripheral swelling, Upper-airway cough syndrome, Infection, Illness, Product use issue, Therapy interrupted, |
||||
LENALIDOMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, GABAPENTIN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ERYTHROPOIETIN, SILDENAFIL CITRATE, |
||||
| 1233 | 24985288 |
69 | 2 | |
Illness, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 1234 | 24985484 |
65 | 1 | |
Sinusitis, Therapy interrupted, |
||||
TOFACITINIB, |
||||
| 1235 | 24986422 |
2 | ||
Therapy interrupted, |
||||
VIGABATRIN, CALCIUM CARBONATE, ANTACID, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, ERGOCALCIFEROL, |
||||
| 1236 | 24973679 |
US |
2 | |
Psoriasis, Therapy interrupted, |
||||
APREMILAST, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, CICLOPIROX, LEVOTHYROXINE, |
||||
| 1237 | 24975065 |
US |
64 | 1 |
Hypoaesthesia, Diarrhoea, Product supply issue, Therapy interrupted, Upper respiratory tract infection, Pyrexia, Off label use, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 1238 | 24975458 |
JP |
2 | |
Fracture, Fall, Therapy interrupted, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 1239 | 24975779 |
US |
73 | 1 |
Insurance issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1240 | 24975879 |
US |
||
Therapy interrupted, |
||||
BOSENTAN, |
||||
| 1241 | 24975945 |
US |
66 | 1 |
Product prescribing error, Therapy interrupted, Product use issue, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 1242 | 24976012 |
US |
||
Renal transplant, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 1243 | 24976042 |
US |
2 | |
Device difficult to use, Drug dose omission by device, Wrong technique in product usage process, Therapy interrupted, Migraine, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, GALCANEZUMAB-GNLM, |
||||
| 1244 | 24976086 |
US |
||
Brain injury, HIV infection, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 1245 | 24976191 |
GB |
41 | 2 |
Psoriatic arthropathy, Therapy interrupted, Product availability issue, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 1246 | 24976199 |
BR |
||
Intestinal perforation, Product supply issue, Therapy interrupted, Drug ineffective, |
||||
INFLIXIMAB, MESALAMINE, AZATHIOPRINE, |
||||
| 1247 | 24976208 |
US |
68 | 1 |
Insurance issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1248 | 24976294 |
GB |
2 | |
Tachycardia, Therapy interrupted, Inappropriate schedule of product administration, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, |
||||
| 1249 | 24976296 |
US |
63 | 2 |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1250 | 24976297 |
US |
80 | 1 |
Pain, Product prescribing issue, Therapy interrupted, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 1251 | 24976304 |
US |
2 | |
Death, Oxygen therapy, Neoplasm malignant, Mechanical ventilation, Nasopharyngitis, Influenza, Laziness, Dysgeusia, Cough, Diarrhoea, Malaise, Intentional dose omission, Product dose omission issue, Therapy interrupted, Product distribution issue, Device issue, |
||||
AMIKACIN, |
||||
| 1252 | 24976401 |
US |
2 | |
Pruritus, Skin irritation, Therapy interrupted, Intentional product misuse, |
||||
APREMILAST, |
||||
| 1253 | 24976427 |
AR |
11 | 2 |
Growth retardation, Incorrect route of product administration, Product availability issue, Therapy interrupted, |
||||
SOMATROPIN, SOMATROPIN, SOMATROPIN, SOMATROPIN, SOMATROPIN, TRIPTORELIN, |
||||
| 1254 | 24976448 |
US |
1 | |
Hospitalisation, Illness, Living in residential institution, Asthenia, Aphonia, Product dose omission issue, Accidental underdose, Therapy interrupted, Device issue, Drug dose omission by device, |
||||
AMIKACIN, AMIKACIN, |
||||
| 1255 | 24976578 |
DE |
10 | 1 |
Immunosuppression, Sepsis, Gastrointestinal disorder, Biopsy kidney, Photophobia, Aphthous ulcer, Nasopharyngitis, Infection, Headache, Therapy interrupted, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, SIROLIMUS, CYCLOSPORINE, AMLODIPINE, VALSARTAN, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, MAGNESIUM, ERGOCALCIFEROL, |
||||
| 1256 | 24976671 |
US |
77 | 2 |
Therapy interrupted, Product distribution issue, |
||||
LENALIDOMIDE, |
||||
| 1257 | 24976776 |
US |
||
Seizure, Migraine, Therapy interrupted, |
||||
ESLICARBAZEPINE ACETATE, |
||||
| 1258 | 24976872 |
ES |
10 | 1 |
Surgery, Intentional dose omission, Therapy interrupted, Device dispensing error, |
||||
| 1259 | 24976918 |
CO |
69 | 1 |
Incorrect dose administered, Therapy interrupted, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, CARVEDILOL, LOSARTAN, |
||||
| 1260 | 24976974 |
IN |
35 | 2 |
Withdrawal syndrome, Maternal exposure during pregnancy, Treatment noncompliance, Psychotic symptom, Therapy interrupted, |
||||
OLANZAPINE, |
||||
| 1261 | 24977237 |
GB |
1 | |
Infection, Syncope, Leukocytosis, Neutrophilia, Therapy interrupted, |
||||
CLOZAPINE, |
||||
| 1262 | 24977250 |
US |
72 | 2 |
Product prescribing issue, Off label use, Insurance issue, Therapy interrupted, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 1263 | 24977303 |
US |
47 | 2 |
Illness, Therapy interrupted, |
||||
SAPROPTERIN DIHYDROCHLORIDE, |
||||
| 1264 | 24977348 |
US |
79 | 1 |
Pulmonary oedema, Influenza like illness, Therapy interrupted, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 1265 | 24977822 |
US |
80 | 2 |
Product prescribing issue, Therapy interrupted, |
||||
| 1266 | 24978287 |
US |
2 | |
Musculoskeletal disorder, Therapy interrupted, |
||||
APREMILAST, |
||||
| 1267 | 24978373 |
US |
||
Dementia, Muscular weakness, Balance disorder, Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, FENOFIBRATE, GLIPIZIDE, IPRATROPIUM BROMIDE, EMPAGLIFLOZIN, CLOPIDOGREL, MONTELUKAST SODIUM, ERGOCALCIFEROL, SIMVASTATIN, |
||||
| 1268 | 24980932 |
73 | 2 | |
Localised infection, Therapy interrupted, |
||||
TOCILIZUMAB, |
||||
| 1269 | 24980951 |
2 | ||
Multiple sclerosis relapse, Therapy interrupted, |
||||
INTERFERON BETA-1A, |
||||
| 1270 | 24981007 |
54 | 2 | |
Illness, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 1271 | 24981010 |
82 | 2 | |
Pneumonia, Cardiac disorder, Therapy interrupted, Diarrhoea, |
||||
APREMILAST, |
||||
| 1272 | 24981039 |
51 | 2 | |
Illness, Therapy interrupted, |
||||
SECUKINUMAB, |
||||
| 1273 | 24981043 |
29 | 1 | |
Pyrexia, Feeling cold, Night sweats, Respiratory tract congestion, Product use issue, Therapy interrupted, |
||||
SECUKINUMAB, |
||||
| 1274 | 24981062 |
67 | 2 | |
Streptococcal infection, Influenza, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 1275 | 24981070 |
41 | 2 | |
Nasopharyngitis, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 1276 | 24981073 |
56 | 2 | |
Influenza, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 1277 | 24981078 |
77 | 2 | |
Pneumonia, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 1278 | 24981094 |
54 | 2 | |
Illness, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 1279 | 24981350 |
72 | 1 | |
Therapy interrupted, Hypoaesthesia, |
||||
| 1280 | 24981362 |
71 | 2 | |
Influenza, Chest pain, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 1281 | 24981693 |
74 | 2 | |
Internal haemorrhage, Therapy interrupted, |
||||
AVACOPAN, AVACOPAN, |
||||
| 1282 | 24981783 |
66 | 1 | |
Infusion related reaction, Pruritus, Erythema, Urticaria, Therapy interrupted, |
||||
| 1283 | 24981786 |
68 | 1 | |
Hypertension, Inappropriate schedule of product administration, Lip swelling, Circumoral swelling, Dermatitis, Infusion related reaction, Therapy interrupted, |
||||
| 1284 | 24981835 |
9 | ||
Documented hypersensitivity to administered product, Pruritus, Erythema, Therapy interrupted, Incorrect drug administration rate, Device malfunction, Pyrexia, Flushing, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 1285 | 24980911 |
61 | 2 | |
Adverse drug reaction, Therapy interrupted, |
||||
MACITENTAN, |
||||
| 1286 | 24980916 |
36 | 2 | |
Pneumonia, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 1287 | 24967644 |
US |
2 | |
Therapy interrupted, |
||||
EVOLOCUMAB, |
||||
| 1288 | 24967693 |
US |
59 | 2 |
Insurance issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1289 | 24967966 |
US |
70 | 1 |
Mental status changes, Cerebrovascular accident, Therapy interrupted, |
||||
AMLODIPINE, CARVEDILOL, CLONIDINE, HYDRALAZINE HYDROCHLORIDE, LOSARTAN, FERRIC CITRATE, |
||||
| 1290 | 24968376 |
US |
2 | |
Therapy interrupted, Unevaluable event, |
||||
EVOLOCUMAB, |
||||
| 1291 | 24968661 |
CA |
74 | 1 |
Hospitalisation, Hypertension, Infusion site discolouration, Infusion site erythema, Infusion site haemorrhage, Infusion site swelling, Injection site discomfort, Injection site swelling, Therapy interrupted, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, ATORVASTATIN CALCIUM, |
||||
| 1292 | 24968931 |
US |
2 | |
Memory impairment, Therapy interrupted, |
||||
| 1293 | 24968950 |
US |
71 | 1 |
Product prescribing issue, Therapy interrupted, Product dose omission issue, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 1294 | 24969070 |
IT |
||
Premature delivery, Ultrasound Doppler abnormal, Placenta praevia, Crohn^s disease, Gestational diabetes, Remission not achieved, Lactation disorder, Condition aggravated, Arthritis, Maternal exposure during pregnancy, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 1295 | 24969201 |
US |
71 | 2 |
Device difficult to use, Therapy interrupted, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 1296 | 24969229 |
US |
||
Therapy interrupted, |
||||
BOSENTAN, |
||||
| 1297 | 24969414 |
US |
70 | 2 |
COVID-19, Rash erythematous, Blister, Insomnia, Cough, Therapy interrupted, |
||||
| 1298 | 24969495 |
CA |
30 | 2 |
Therapy interrupted, Heavy menstrual bleeding, Dermatitis contact, Emotional disorder, Impaired quality of life, In vitro fertilisation, Infusion site haemorrhage, Infusion site mass, Infusion site scar, Injection site bruising, Malaise, Meniscus injury, Nausea, Off label use, Panic attack, Product administration error, Thrombosis, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, APIXABAN, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FOLIC ACID, METFORMIN HYDROCHLORIDE, PANTOPRAZOLE, ERGOCALCIFEROL, |
||||
| 1299 | 24969818 |
CA |
57 | 1 |
Umbilical hernia, Amnesia, Arrhythmia, Asthenia, Back pain, Blood pressure decreased, Cardiac failure, Condition aggravated, Crohn^s disease, Dehydration, Diarrhoea, Erythema, Fall, Fungal infection, Gait inability, Illness, Inappropriate schedule of product administration, Leg amputation, Lip dry, Necrotising colitis, Necrotising fasciitis, Off label use, Osteoporosis, Peripheral swelling, Pleural effusion, Pulse absent, Pyrexia, Renal failure, Sepsis, Spinal fracture, Suicidal ideation, Therapy interrupted, Thirst, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 1300 | 24969840 |
CA |
22 | 1 |
Contusion, Haemophagocytic lymphohistiocytosis, Immunoglobulins decreased, Infusion site swelling, Platelet count decreased, Therapy interrupted, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, ACYCLOVIR, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28